Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives.
Cancers (Basel)
; 15(15)2023 Aug 06.
Article
en En
| MEDLINE
| ID: mdl-37568804
ABSTRACT
Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Guideline
Idioma:
En
Año:
2023
Tipo del documento:
Article